In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma
- 1 July 1991
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 21 (7) , 1759-1762
- https://doi.org/10.1002/eji.1830210727
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor.The Journal of Experimental Medicine, 1990
- Characterization of a new IgGλ myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myelomaBritish Journal of Haematology, 1990
- Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.The Journal of Experimental Medicine, 1990
- Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.Journal of Clinical Investigation, 1989
- Interleukin 6 gene expression in normal and neoplastic B cells.Journal of Clinical Investigation, 1989
- Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6Blood, 1989
- Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.The Journal of Experimental Medicine, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- A Growth Factor Required by Plasmacytoma Cells In VitroPublished by Springer Nature ,1986
- Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissuesNucleic Acids Research, 1984